retatrutide weight loss clinical trial eli lilly phase 3 A new trial from Eli Lilly and Company suggests Experimental drug Retatrutide shows promising
Description
Studies have shown that significant weight loss can improve liver function and even reverse liver damage in some cases
Changes in Lean Body Mass With Glucagon-Like Peptide-1-Based Therapies and Mitigation Strategies
Will Yancy, Medical Director at the Duke Lifestyle and Weight Management Center
Gut Microbes 2023;15:2274124
Medical Disclaimer This article provides educational information about Retatrutide maintenance and should not be considered medical advice
